Skip to main content
OpenTrials
Completed

NCT Number: NCT04538716

Retroseptal Transconjunctival Blepharoplasty for GIR

The tear trough deformity is a challenging cosmetic condition.surgical treatment and filling are good treatment options

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

INMC

Abu Dhabi, 46266, United Arab Emirates

About this study

Procedure is lower eyelid transconjunctival Blepharoplasty associated with stromal vascular fraction gel (SVF-gel) or fat transposition

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • tear trough deformity

Exclusion criteria

  • Eyelid diseases and previous eyelid surgery

Treatment and study plan

transconjunctival lower blepharoplasty

Procedure

transconjunctival lower blepharoplasty associated with stromal vascular fraction gel (SVF-gel)

Primary outcomes

  1. skin-periosteal depth

    Time frame: 2 years

    measure skin-periosteal depth

Secondary outcomes

  1. global aesthetic improvement scale

    Time frame: 2 years

    calculate scale score from score 1 (exceptional improvement) to score 5 (worsening patient)

Sponsors and collaborators

Lead sponsor

Benha University

Other

Registry information

Official study title

Orbital Fat Graft Retroseptal Transconjunctival Blepharoplasty for Treatment of Groove in the Infraorbital Region

Important dates

Study start
2019
Primary completion
2023
Study completion
2023
First posted
Sep 4, 2020
Registry last updated
Nov 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.